Ask AI
ProCE Banner Activity

Gaps and Unmet Needs in PBC Care

Podcast Episodes

Join expert faculty, Dr Alan Bonder and Dr Stuart Gordon, to learn more about key gaps in PBC management and how these shortfalls can be addressed through identification of appropriate biochemical goals, proper assessment and management of PBC symptoms, and current second-line therapies. 

Released: November 21, 2025

Share

Provided by

Provided by Clinical Care Options, LLC.

ProCE Banner

Supporters

Supported by an educational grant from Gilead Sciences, Inc.

Gilead Sciences, Inc.

Target Audience

This program is intended for physicians, including hepatologists and gastroenterologists, nurse practitioners, physician associates, nurses, pharmacists, and other healthcare professionals involved in the care of patients with PBC.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Evaluate biochemical response to first-line PBC therapy based on optimal timing and criteria

  • Develop personalized management plans for patients with PBC based on risk factors, comorbidities, and symptoms

  • Apply best practices to select appropriate second-line PBC therapy

Faculty Disclosure

Primary Author

Alan Bonder, MD, AGAF: consultant/advisor/speaker: Chemomab, Gilead, Intercept, Ipsen; researcher: Chemomab, Gilead, Intercept, Ipsen.

Stuart C. Gordon, MD, FAASLD: consultant/advisor/speaker: Gilead, GSK, Ipsen.